Items where authors include "Neven, P."

Article

Rugo, H.S. orcid.org/0000-0001-6710-4814, Van Poznak, C.H. orcid.org/0000-0001-5523-6908, Neven, P. orcid.org/0000-0002-1434-9460 et al. (12 more authors) (2024) Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast Cancer Research and Treatment, 204 (2). pp. 249-259. ISSN 0167-6806

Morra, A. orcid.org/0000-0003-4983-7883, Schreurs, M.A.C. orcid.org/0000-0002-1826-5344, Andrulis, I.L. et al. (114 more authors) (2023) Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Medicine, 12 (15). pp. 16142-16162. ISSN 2045-7634

Guo, Q., Burgess, S., Turman, C. et al. (132 more authors) (2017) Body mass index and breast cancer survival: a Mendelian randomization analysis. International Journal of Epidemiology, 46 (6). pp. 1814-1822. ISSN 0300-5771

Guo, Y., Warren Andersen, S., Shu, X.O. et al. (108 more authors) (2016) Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. PLoS Medicine, 13 (8). e1002105. ISSN 1549-1277

Hollestelle, A., van der Baan, F.H., Berchuck, A. et al. (355 more authors) (2016) No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology, 141 (2). pp. 386-401. ISSN 0090-8258

Zhao, Z., Wen, W., Michailidou, K. et al. (115 more authors) (2016) Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes and Control. pp. 1-15. ISSN 0957-5243

Forbes, J.F., Sestak, I., Howell, A. et al. (13 more authors) (2016) Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial. Lancet, 387 (10021). pp. 866-873. ISSN 0140-6736

Hamdi, Y., Soucy, P., Adoue, V. et al. (93 more authors) (2016) Association of Breast Cancer Risk with Genetic Variants Showing Differential Allelic Expression: Identification of a Novel Breast Cancer Susceptibility Locus at 4q21. Oncotarget, 7. pp. 80140-80163. ISSN 1949-2553

Michailidou, K., Beesley, J., Lindstrom, S. et al. (245 more authors) (2015) Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature Genetics, 47. pp. 373-380. ISSN 1061-4036

Johnson, N., Dudbridge, F., Orr, N. et al. (182 more authors) (2014) Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Breast Cancer Research , 16 (3). R51. ISSN 1465-5411

Nickels, S., Truong, T., Hein, R. et al. (93 more authors) (2013) Evidence of Gene-Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors. PLoS Genetics, 9 (3). e1003284. ISSN 1553-7404

Hein, R., Maranian, M., Hopper, J.L. et al. (168 more authors) (2012) Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS ONE, 7 (8). e42380. ISSN 1932-6203